BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 23460038)

  • 1. Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells.
    Polanska UM; Orimo A
    J Cell Physiol; 2013 Aug; 228(8):1651-7. PubMed ID: 23460038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental generation of carcinoma-associated fibroblasts (CAFs) from human mammary fibroblasts.
    Polanska UM; Acar A; Orimo A
    J Vis Exp; 2011 Oct; (56):e3201. PubMed ID: 22064505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
    Peng Y; Li Z; Li Z
    Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors.
    Lebret SC; Newgreen DF; Thompson EW; Ackland ML
    Breast Cancer Res; 2007; 9(1):R19. PubMed ID: 17311675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
    Cirri P; Chiarugi P
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):195-208. PubMed ID: 22101652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies.
    Yoshida GJ; Azuma A; Miura Y; Orimo A
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067787
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.
    Shimoda M; Mellody KT; Orimo A
    Semin Cell Dev Biol; 2010 Feb; 21(1):19-25. PubMed ID: 19857592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 22 : 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis.
    Bianchini F; Giannoni E; Serni S; Chiarugi P; Calorini L
    Br J Nutr; 2012 Dec; 108(12):2129-37. PubMed ID: 22390897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
    Micke P; Ostman A
    Lung Cancer; 2004 Aug; 45 Suppl 2():S163-75. PubMed ID: 15552797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human lung cancer-associated fibroblasts in three-dimensional in vitro co-culture model.
    Horie M; Saito A; Mikami Y; Ohshima M; Morishita Y; Nakajima J; Kohyama T; Nagase T
    Biochem Biophys Res Commun; 2012 Jun; 423(1):158-63. PubMed ID: 22634307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.
    Mazzocca A; Dituri F; Lupo L; Quaranta M; Antonaci S; Giannelli G
    Hepatology; 2011 Sep; 54(3):920-30. PubMed ID: 21674557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta in CAF-mediated tumor growth and metastasis.
    Calon A; Tauriello DV; Batlle E
    Semin Cancer Biol; 2014 Apr; 25():15-22. PubMed ID: 24412104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.
    Bremnes RM; Dønnem T; Al-Saad S; Al-Shibli K; Andersen S; Sirera R; Camps C; Marinez I; Busund LT
    J Thorac Oncol; 2011 Jan; 6(1):209-17. PubMed ID: 21107292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of fibroblasts in cancer stroma.
    Räsänen K; Vaheri A
    Exp Cell Res; 2010 Oct; 316(17):2713-22. PubMed ID: 20451516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment.
    Ellem SJ; Taylor RA; Furic L; Larsson O; Frydenberg M; Pook D; Pedersen J; Cawsey B; Trotta A; Need E; Buchanan G; Risbridger GP
    J Pathol; 2014 Sep; 234(1):86-98. PubMed ID: 25042571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas.
    Mezawa Y; Orimo A
    Cell Tissue Res; 2016 Sep; 365(3):675-89. PubMed ID: 27506216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized β-catenin in carcinoma-associated fibroblasts.
    Verghese ET; Shenoy H; Cookson VJ; Green CA; Howarth J; Partanen RH; Pollock S; Waterworth A; Speirs V; Hughes TA; Hanby AM
    Histopathology; 2011 Oct; 59(4):609-18. PubMed ID: 22014042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
    Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
    BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the tumor stroma as a novel therapeutic approach for prostate cancer.
    Franco OE; Hayward SW
    Adv Pharmacol; 2012; 65():267-313. PubMed ID: 22959029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.